APA (7th ed.) Citation

Stephen S Whitehead, Anna P Durbin, Kristen K Pierce, Dan Elwood, Benjamin D McElvany, Ellen A Fraser, . . . Beth D Kirkpatrick. (2017). In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Stephen S Whitehead, et al. In a Randomized Trial, the Live Attenuated Tetravalent Dengue Vaccine TV003 Is Well-tolerated and Highly Immunogenic in Subjects with Flavivirus Exposure Prior to Vaccination. Public Library of Science (PLoS), 2017.

MLA (9th ed.) Citation

Stephen S Whitehead, et al. In a Randomized Trial, the Live Attenuated Tetravalent Dengue Vaccine TV003 Is Well-tolerated and Highly Immunogenic in Subjects with Flavivirus Exposure Prior to Vaccination. Public Library of Science (PLoS), 2017.